Ohcanbohtosat - Matthias Kloor

Aiddostahte ozu
  1. 1
    HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

    HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance Dahkki Barbara Seliger, Matthias Kloor, Soldano Ferrone

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP

    Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP Dahkki Arne Warth, Matthias Kloor, Peter Schirmacher, Hendrik Bläker

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Immune evasion of microsatellite unstable colorectal cancers

    Immune evasion of microsatellite unstable colorectal cancers Dahkki Matthias Kloor, Sara Michel, Magnus von Knebel Doeberitz

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells

    Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells Dahkki Susanne Dihlmann, Matthias Kloor, Christine Fallsehr, Magnus von Knebel Doeberitz

    Almmustuhtton 2005
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Complex pattern of immune evasion in MSI colorectal cancer

    Complex pattern of immune evasion in MSI colorectal cancer Dahkki Mine Özcan, Jonas Janikovits, Magnus von Knebel Doeberitz, Matthias Kloor

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Vaccines for immunoprevention of DNA mismatch repair deficient cancers

    Vaccines for immunoprevention of DNA mismatch repair deficient cancers Dahkki Alejandro Hernandez‐Sanchez, Mark Grossman, Kevin Yeung, Shizuko Sei, Steven M. Lipkin, Matthias Kloor

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Somatic Hypermethylation of <i>MSH2</i> Is a Frequent Event in Lynch Syndrome Colorectal Cancers

    Somatic Hypermethylation of <i>MSH2</i> Is a Frequent Event in Lynch Syndrome Colorectal Cancers Dahkki Takeshi Nagasaka, Jennifer Rhees, Matthias Kloor, Johannes Gebert, Yoshio Naomoto, C. Richard Boland, Ajay Goel

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses

    Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses Dahkki Prudence R. Carr, Elizabeth Alwers, Stefanie Bienert, Janick Weberpals, Matthias Kloor, Hermann Brenner, Michael Hoffmeister

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

    Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases Dahkki Annick Buckowitz, HP Knaebel, Axel Benner, Hendrik Bläker, Johannes Gebert, P. Kienle, Magnus von Knebel Doeberitz, Matthias Kloor

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment

    Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment Dahkki Michael Hoffmeister, Lina Jansen, Anja Rudolph, Csaba Tóth, Matthias Kloor, Wilfried Roth, Hendrik Bläker, Jenny Chang‐Claude, Hermann Brenner

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer

    BRAF V600E‐specific immunohistochemistry for the exclusion of Lynch syndrome in MSI‐H colorectal cancer Dahkki David Capper, Anita Y. Voigt, Gergana Bozukova, Aysel Ahadova, Philipp Kickingereder, Andreas von Deimling, Magnus von Knebel Doeberitz, Matthias Kloor

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

    High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability Dahkki Sara Michel, Axel Benner, Mirjam Tariverdian, Nicolas Wentzensen, P. Hoefler, Thora Pommerencke, Niels Grabe, Magnus von Knebel Doeberitz, Matthias Kloor

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden

    Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden Dahkki Jan Budczies, Anja Seidel, Petros Christopoulos, Volker Endris, Matthias Kloor, Balázs Győrffy, Barbara Seliger, Peter Schirmacher, Albrecht Stenzinger, Carsten Denkert

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

    Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies Dahkki Shizuko Sei, Aysel Ahadova, Derin B. Keskin, Lena Bohaumilitzky, Johannes Gebert, Magnus von Knebel Doeberitz, Steven M. Lipkin, Matthias Kloor

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

    Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial Dahkki A Tikidzhieva, Axel Benner, Sara Michel, A. Formentini, K. H. Link, Wolfgang Dippold, Magnus von Knebel Doeberitz, Marko Kornmann, Matthias Kloor

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers

    Immune Response Against Frameshift-Induced Neopeptides in HNPCC Patients and Healthy HNPCC Mutation Carriers Dahkki Yvette Schwitalle, Matthias Kloor, Susanne Eiermann, Michael Linnebacher, Peter Kienle, H. P. Knaebel, Mirjam Tariverdian, Axel Benner, Magnus von Knebel Doeberitz

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes

    Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes Dahkki Sara Michel, Michael Linnebacher, Joshua Alcaniz, Maike Voss, Rudolf Wagner, Wolfgang Dippold, Christina Becker, Magnus von Knebel Doeberitz, Soldano Ferrone, Matthias Kloor

    Almmustuhtton 2009
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients

    High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients Dahkki Miriam Reuschenbach, Thuong Hien Tran, Franziska Faulstich, Wolfgang Hartschuh, Svetlana Vinokurova, Matthias Kloor, Ellen Krautkrämer, Martin Zeier, Magnus von Knebel Doeberitz, Claudia Sommerer

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial

    A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial Dahkki Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad‐Reza Rafiyan, Salah‐Eddin Al‐Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival

    Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival Dahkki M Bickeböller, Katrin E. Tagscherer, Matthias Kloor, Lina Jansen, Jenny Chang‐Claude, Hermann Brenner, Michael Hoffmeister, C Tóth, Peter Schirmacher, Wilfried Roth, Hendrik Bläker

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: